Expired semaglutide is not acutely toxic, but potency is compromised, reducing therapeutic benefit
Overall, the results remained robust in several sensitivity analyses
A pharmacokinetic study examining oral semaglutide, a related GLP-1 medication , found that levothyroxine exposure increased by approximately 33% when the two drugs were taken together
It is the foundation of safe semaglutide use
Reddy explained that when drug companies conduct clinical trials to get FDA approval, they must collect and report all adverse events that occur more in patients receiving the drug than those in the placebo group
Peak anti-inflammatory benefit appears to coincide with the period of most active weight loss (months 3 through 9), though improvements persist as long as treatment continues